Compare DNA & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNA | SVC |
|---|---|---|
| Founded | 2008 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 835.7M | 839.2M |
| IPO Year | 2020 | 1995 |
| Metric | DNA | SVC |
|---|---|---|
| Price | $8.50 | $5.82 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $8.00 | ★ $9.67 |
| AVG Volume (30 Days) | ★ 2.4M | 1.5M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 3.51% |
| EPS Growth | ★ 46.49 | 26.95 |
| EPS | N/A | ★ N/A |
| Revenue | $170,155,000.00 | ★ $1,814,838,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.59 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.37 | $1.13 |
| 52 Week High | $18.22 | $9.02 |
| Indicator | DNA | SVC |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | 44.74 |
| Support Level | $6.65 | $5.65 |
| Resistance Level | $10.34 | $6.47 |
| Average True Range (ATR) | 1.53 | 0.38 |
| MACD | -0.30 | -0.01 |
| Stochastic Oscillator | 2.03 | 50.51 |
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its segments hotel investment unit, and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza, Hyatt Place, and others.